STOCK TITAN

Cellebrite DI Ltd. (CLBT) Stock Price, News & Analysis

CLBT NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
29 252 sessions, November 11, 2025 to November 11, 2026
Largest daily move
-29.2% close of August 13, 2026
1-year change
-19.1% closing prices, November 11, 2025 to November 11, 2026
1-month change
+12.8% closing prices, October 9, 2026 to November 11, 2026

Company Description

Cellebrite DI Ltd. (NASDAQ: CLBT) is a digital intelligence and investigative software company that focuses on helping public and private sector customers work with digital evidence. According to the company’s public disclosures, its mission is to enable global customers to protect and save lives by enhancing digital investigations and intelligence gathering to accelerate justice in communities around the world. Cellebrite is classified in the Information sector under software publishers and is listed on the Nasdaq stock exchange.

The company describes itself as a global leader in digital investigative and intelligence solutions for the public and private sectors. Thousands of public safety organizations, intelligence agencies, defense organizations and businesses rely on its AI-powered software portfolio and Digital Investigation Platform to lawfully access, collect, analyze and share digital data in legally sanctioned investigations while preserving data privacy. Cellebrite reports that its technology is used in more than 1.5 million investigations globally each year and that more than 7,000 customers worldwide use its solutions to advance their missions, elevate public safety and safeguard data privacy.

Business focus and digital investigation platform

Cellebrite’s core focus is on digital investigations, digital forensics and intelligence analytics. Its AI-powered Digital Investigation Platform is designed to support the full lifecycle of a legally sanctioned investigation, from data collection and evidence extraction through review, analysis, collaboration and secure sharing. The platform is available in cloud, on‑premises and hybrid deployments, and the company emphasizes support for legally compliant workflows and chain‑of‑custody requirements.

Based on company statements in recent releases, the platform includes digital forensic tools, investigative analytics and evidence management capabilities. Customers use these tools in investigations involving areas such as child exploitation, homicide, terrorism, border control, sex crimes, drugs and other organized crime, human trafficking, fraud, intellectual property theft, financial crimes, internal investigations and eDiscovery cases. The company highlights that its technology is used to make forensically sound digital data more accessible and actionable, and to accelerate time to evidence in legally sanctioned investigations.

Key solutions and technology areas

Cellebrite’s disclosures and product references indicate several important solution areas within its portfolio:

  • Digital forensics and device access: Cellebrite provides digital forensics software that supports access to and analysis of data from mobile devices and other digital sources. The company’s flagship digital forensics solution, Cellebrite Inseyets, is described as enabling expanded access to Android and iOS devices and versions, enhancing digital evidence collection and review and adding field‑ready workflows. Inseyets also supports integration with other Cellebrite solutions for faster time to evidence and collaboration.
  • Investigative review, collaboration and evidence management: The Guardian suite is presented as a set of SaaS offerings for digital forensics, investigations and analytics across public and private sectors. Guardian is used for collaborative digital evidence review, sharing and storage, and for managing investigative workflows. The company has also introduced Guardian Investigate, described as a SaaS‑based investigative solution that uses agentic AI to analyze multiple evidence types such as mobile data, call detail records, open‑source intelligence and case files, along with workflows to support team collaboration.
  • Investigative data analytics: Cellebrite references Pathfinder as its multi‑device investigative data analytics solution. Pathfinder is offered with deployment options including AWS GovCloud, with cost‑optimized configurations tailored to specific requirements in a virtual private cloud environment.
  • Government cloud and compliance: The company has developed Cellebrite Government Cloud (CGC), which is described as launching with a suite of digital investigative tools. CGC provides U.S. federal agencies secure access to solutions such as Cellebrite Inseyets and Cellebrite Guardian in a cloud environment. CGC has achieved FedRAMP High Ready status, and the U.S. Department of Justice has agreed to serve as the sponsoring agency for the platform’s pursuit of a FedRAMP High authorization, a step intended to advance CGC toward full Authorization to Operate.
  • Mobile virtualization and security research: Through a reseller agreement and subsequent acquisition of Corellium, a provider of Arm‑based virtualization software, Cellebrite has added mobile virtualization capabilities to its portfolio. Corellium technology brings iOS, Android and IoT device analysis capabilities used for security research and testing within defense, intelligence and other government agencies and enterprise customers. The combination is described by the company as extending its digital investigation platform to include virtual device testing and mobile vulnerability research.

Customer base and use cases

Cellebrite’s public statements emphasize a broad global customer base across public safety, defense, intelligence and enterprise segments. The company notes that thousands of public safety organizations, intelligence agencies and businesses rely on its digital forensic and investigative solutions. Use cases cited by the company include investigations into child sexual abuse material, homicide, terrorism, border control issues, sex crimes, drug trafficking and other organized crime, human trafficking, fraud, intellectual property theft, financial crimes, internal corporate investigations and eDiscovery matters.

The company also highlights internal investigations and application security testing as areas where its technology is applied. For example, Guardian for enterprises and service providers is described as supporting internal investigations by enabling efficient review of collected data and faster location of preliminary evidence, reducing reliance on specialized forensic teams. Corellium‑based offerings are used for mobile vulnerability research, application security testing and malware analysis to help minimize risks and meet regulatory requirements.

AI, cloud and agentic capabilities

Cellebrite repeatedly references AI‑powered capabilities across its portfolio. The Digital Investigation Platform is described as AI‑powered, and Guardian Investigate is specifically noted as using agentic AI to analyze multiple evidence types and unify investigative information in one place. The company also points to advanced AI‑powered analysis features that span collection, review and analytics, supporting faster time to evidence and more efficient investigative workflows.

Cloud deployment is another focus area. Cellebrite offers its solutions via cloud, on‑premises and hybrid models, and has introduced AWS GovCloud deployment options for Pathfinder. The Cellebrite Government Cloud is positioned as a way for U.S. federal agencies and attorneys to gain secure, flexible access to evidence from anywhere while using advanced analytical capabilities enabled by cloud infrastructure. At the same time, the company states that agencies will continue to have access to on‑premises, hybrid and fully offline solutions to address diverse mission and regulatory requirements.

Corporate status and regulatory filings

Cellebrite DI Ltd. files reports with the U.S. Securities and Exchange Commission as a foreign private issuer on Form 20‑F and Form 6‑K. Recent Form 6‑K filings reference press releases announcing quarterly financial results and shareholder meeting outcomes. The company reports that shareholders approved all proposals at its annual general meeting held in September 2025, with a significant portion of outstanding ordinary shares present or represented by proxy. These filings are incorporated by reference into existing registration statements on Form S‑8 and Form F‑3.

The company’s disclosures also note its operations in Israel and reference risk factors related to geopolitical conditions, regulatory constraints, technology evolution, competition, data privacy, cybersecurity, use of artificial intelligence and other considerations, as described in its annual report on Form 20‑F and other SEC filings.

Strategic developments and partnerships

Recent announcements highlight several strategic developments. Cellebrite has completed the acquisition of Corellium, adding Arm‑based virtualization technology and technical talent to its platform. The company states that this combination creates a digital investigation portfolio spanning physical device access, virtual device testing and real‑time intelligence, enabling investigators, security researchers and intelligence professionals to work without physical device constraints and to accelerate time to evidence and threat detection.

Cellebrite also reports an expanded relationship with the National Center for Missing and Exploited Children (NCMEC). The company has integrated NCMEC’s CyberTipline hash value list within Cellebrite Inseyets, allowing public safety agencies to identify known child sexual abuse material files more quickly. This integration is described as helping speed up investigations involving crimes against children and reducing time to evidence and justice for victims and survivors.

In addition, Cellebrite organizes the C2C User Summit, which it describes as a digital investigation and intelligence industry event attended by public safety and private sector professionals. The summit features training, networking, thought leadership content and the Digital Justice Awards (the “Justys”), which recognize digital forensic and investigative professionals for their impact in their communities.

Risk considerations and regulatory environment

In its forward‑looking statements and risk factor summaries, Cellebrite highlights a range of risks that could affect its business and financial performance. These include the need to keep pace with technological advances and evolving industry standards, dependence on law enforcement and government agencies for a material portion of solution adoption, potential errors or defects in digital investigation solutions, competition in its markets, the possibility of misuse of its solutions, challenges in managing growth, dependency on subscription renewals, risks associated with the use of artificial intelligence, supply risks for hardware components, lengthy sales cycles, and geopolitical and regulatory risks related to its international operations and operations in Israel.

The company also notes risks related to cybersecurity, negative publicity, intellectual property, different corporate governance requirements for Israeli companies, market volatility in its share price, changing tax laws and regulations, and compliance with anti‑corruption, trade compliance, anti‑money‑laundering and economic sanctions laws and regulations. These risk factors are detailed in its annual report on Form 20‑F and other SEC filings.

How investors and analysts may view Cellebrite

From the perspective of investors and analysts researching CLBT stock, Cellebrite represents a software publisher focused on digital intelligence, digital forensics and investigative analytics. The company positions its AI‑powered Digital Investigation Platform as central to lawfully accessing and analyzing digital evidence, with a customer base that includes thousands of public safety organizations, intelligence agencies and enterprises worldwide. Its strategy includes expanding cloud‑based offerings, advancing government cloud compliance such as FedRAMP, integrating mobile virtualization technology through Corellium and deepening partnerships with organizations involved in public safety and child protection.

Stock Performance

$12.80
+0.81%
+0.10
Pre-marketLast updated: November 12, 2026 at 04:54
-19.1%
Performance 1 year

Cellebrite DI Ltd. (CLBT) closed at $12.70 on November 11, 2026. Over the past 12 months, the price has lost 19.1%.

See what a $1,000 investment in CLBT would be worth today

Average down calculator for CLBT

CLBT Metrics & Rankings

Price returns through November 11, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

SEC Filings

Cellebrite DI Ltd. has filed 10 recent SEC filings, including 6 Form 144, 3 Form 4, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLBT SEC filings →

Insider Radar

Net Sellers
90-Day Summary
0
Shares Bought
56,516
Shares Sold
5
Transactions
Most Recent Transaction
Barter David (Chief Financial Officer) sold 12,134 shares @ $11.21 on October 16, 2026

Insider selling at Cellebrite DI Ltd. over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

Cellebrite DI Ltd. generated $475.7M in revenue in FY2025, retaining a 84.2% gross margin, operating income reached $66.5M (14.0% operating margin), and net income was $78.3M, reflecting a 16.5% net profit margin. Diluted earnings per share stood at $0.31. The company generated $173.5M in operating cash flow. The current ratio was 1.56, measuring current assets divided by current liabilities.

$475.7M
Revenue (FY2025)
$78.3M
Net Income (FY2025)
$173.5M
Operating Cash Flow

Upcoming Events

NOV
12
November 12, 2026 Earnings

Q3 2026 earnings call

Cellebrite will release Q3 2026 results before U.S. open and host a conference call/webcast at 08:30 EST; updated call-in info.
NOV
12
November 12, 2026 Earnings

Q3 2026 Results Call

Q3 2026 results released before U.S. open Nov 12; live conference call and webcast at 8:30 a.m. ET; IR site will host materials.
YEAR
2027
2027 Product

On-premises Genesis

On-premises Genesis release expected early 2027, enabling agencies to run Cellebrite's AI investigation tool locally in their environment.
YEAR
2027
2027 Product

CFID v4 Support

Next-generation CFID v4 drone forensics support planned early 2027, adding advanced drone data extraction and analysis capabilities.
H1
2027
H1 2027 Corporate

Redomicile completion

Anticipated completion of Cellebrite's U.S. redomicile by H1 2027, pending shareholder and regulatory approvals and SEC filings.
APR
13
April 13, 2027 Marketing

JUSTYS Awards Presentation

Presented Apr 13, 2027 at the C2C User Summit in Dallas; streamed live on Law&Crime Network's YouTube (7.7M subscribers).

Cellebrite DI Ltd. has 6 upcoming scheduled events. The next event, "Q3 2026 earnings call", is scheduled for November 12, 2026 (today). 2 of them are earnings releases or calls. Investors can track these dates to stay informed about potential catalysts that may affect the CLBT stock price.

Short Interest History

Last 12 Months

Short interest in Cellebrite DI Ltd. (CLBT) currently stands at 5.6 million shares, down 21.9% from the previous reporting period, representing 4.5% of the float. Since November 2025, short interest has decreased by 25.6%.

Days to Cover History

Last 12 Months

Days to cover for Cellebrite DI Ltd. (CLBT) currently stands at 4.3 days, up 12.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.4 to 8.8 days.

CLBT Company Profile & Sector Positioning

Cellebrite DI Ltd. (CLBT) operates in the Software - Infrastructure industry within the broader Technology sector and is listed on the NASDAQ.

Investors comparing CLBT often look at related companies in the same sector, including WIX.com Ltd. (WIX), AvePoint, Inc. (AVPT), Teradata Corporation (TDC), Appian Corporation (APPN), and Shift4 Payments, Inc. (FOUR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLBT's relative position within its industry.

Frequently Asked Questions

The current stock price of Cellebrite DI Ltd. (CLBT) is $12.80 in pre-market trading as of November 12, 2026.

The market cap of Cellebrite DI Ltd. (CLBT) is approximately $3.2B. Learn more about what market capitalization means .

The FY2025 revenue of Cellebrite DI Ltd. (CLBT) is $475.7M, from its most recent completed fiscal year.

The FY2025 net income of Cellebrite DI Ltd. (CLBT) is $78.3M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Cellebrite DI Ltd. (CLBT) is $0.31 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Cellebrite DI Ltd. (CLBT) is $173.5M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Cellebrite DI Ltd. (CLBT) is 16.5% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Cellebrite DI Ltd. (CLBT) is 14.0% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Cellebrite DI Ltd. (CLBT) is 84.2% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Cellebrite DI Ltd. (CLBT), current assets divided by current liabilities, was 1.56 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Cellebrite DI Ltd. (CLBT) is $400.5M for FY2025, its most recent completed fiscal year.

The operating income of Cellebrite DI Ltd. (CLBT) is $66.5M for FY2025, its most recent completed fiscal year. Learn about operating income.

Cellebrite DI Ltd. develops digital investigative and intelligence software used to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations. Its AI-powered Digital Investigation Platform supports digital forensics, investigative review and analytics for public safety organizations, intelligence agencies, defense organizations and businesses.

According to the company, its Digital Investigation Platform enables customers to make forensically sound digital data more accessible and actionable. It supports workflows from data collection and evidence extraction through review, analysis, collaboration and secure sharing, and is available via cloud, on-premises and hybrid deployments.

Cellebrite states that thousands of public safety organizations, intelligence agencies, defense and intelligence organizations and enterprises worldwide rely on its solutions. These customers use the company’s digital forensic and investigative software to advance missions related to public safety, security and internal investigations.

The company reports that its technology is used in more than 1.5 million investigations globally each year, including cases involving child exploitation, homicide, terrorism, border control, sex crimes, drugs and other organized crime, human trafficking, fraud, intellectual property theft, financial crimes, internal investigations and eDiscovery matters.

Cellebrite Inseyets is described as the company’s flagship digital forensics solution. It provides expanded access to Android and iOS devices and versions to enhance digital evidence collection and review, adds field-ready workflows and supports direct integration with the Guardian suite for faster and more secure time to evidence and collaboration.

The Guardian suite is a set of SaaS offerings for digital forensics, investigations and analytics across public and private sectors, supporting collaborative digital evidence review, sharing and storage. Guardian Investigate is a SaaS-based investigative solution within this suite that uses agentic AI to analyze multiple evidence types, such as mobile data, call detail records, open-source intelligence and case files, with workflows designed to support team collaboration.

Cellebrite describes its Digital Investigation Platform as AI-powered and notes that Guardian Investigate uses agentic AI to analyze multiple evidence types. AI capabilities are used to support advanced analysis, unify investigative information and help accelerate time to evidence in legally sanctioned investigations.

Cellebrite Government Cloud is a cloud environment that will launch with a suite of digital investigative tools for U.S. federal agencies. The initial offering provides secure access to solutions such as Cellebrite Inseyets and Cellebrite Guardian. CGC has achieved FedRAMP High Ready status, and the U.S. Department of Justice is serving as the sponsoring agency for its pursuit of a FedRAMP High authorization.

Cellebrite has completed the acquisition of Corellium, a provider of Arm-based virtualization software. The company states that Corellium’s technology and technical talent extend its platform to include mobile virtualization, virtual device testing and mobile vulnerability research, enhancing capabilities for investigators, security researchers and intelligence professionals.

Cellebrite reports an expanded relationship with the National Center for Missing and Exploited Children (NCMEC). It has integrated NCMEC’s CyberTipline hash value list within Cellebrite Inseyets, enabling public safety agencies to immediately pinpoint known child sexual abuse material files and helping to speed up investigations involving crimes against children.

Cellebrite DI Ltd. is listed on the Nasdaq stock exchange under the ticker symbol CLBT, as referenced in its press releases and SEC filings.

As a foreign private issuer, Cellebrite files an annual report on Form 20-F and current reports on Form 6-K with the U.S. Securities and Exchange Commission. Recent Form 6-K filings have included press releases on quarterly financial results and shareholder meeting outcomes, and these filings are incorporated by reference into the company’s registration statements on Form S-8 and Form F-3.